BMI Body mass index
CGM Continuous glucose monitoring
CI Confidence interval
CrCl Creatine clearance
C-peptide Connecting peptide
DEPICT Dapagliflozin Evaluation in Patients with Inadequately Controlled Type 1 diabetes
DKA Diabetic ketoacidosis
EU European Union
GFR Glomerular filtration rate
HbA1c Haemoglobin A1c
HDL High density lipoprotein
IU International unit
LDL Low-density lipoprotein
SGLT-2i Sodium-glucose cotransporter 2 inhibitor
SmPC Summary of product characteristics
SU Sulfonylurea
T1D Type 1 diabetes